|
CDC42BPB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.820200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.500200E-02 |
| Normal-vs-Stage2 |
3.233000E-01 |
| Normal-vs-Stage3 |
4.554200E-01 |
| Normal-vs-Stage4 |
2.915800E-02 |
| Stage1-vs-Stage2 |
9.727200E-01 |
| Stage1-vs-Stage3 |
7.140200E-01 |
| Stage1-vs-Stage4 |
2.526200E-01 |
| Stage2-vs-Stage3 |
8.246000E-01 |
| Stage2-vs-Stage4 |
3.044200E-01 |
| Stage3-vs-Stage4 |
2.456800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.838200E-02 |
| Normal-vs-AfricanAmerican |
2.084000E-01 |
| Normal-vs-Asian |
1.086290E-02 |
| Caucasian-vs-AfricanAmerican |
7.286200E-01 |
| Caucasian-vs-Asian |
4.392200E-01 |
| AfricanAmerican-vs-Asian |
2.982000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.023900E-03 |
| Normal-vs-Female |
6.641800E-01 |
| Male-vs-Female |
1.579850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.309500E-02 |
| Normal-vs-Extreme_Weight |
1.913830E-02 |
| Normal-vs-Obese |
8.237400E-01 |
| Normal-vs-Extreme_Obese |
1.184010E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.627600E-01 |
| Normal_Weight-vs-Obese |
2.063600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.338800E-01 |
| Extreme_Weight-vs-Obese |
1.029420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.216600E-01 |
| Obese-vs-Extreme_Obese |
3.021000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.547200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.384400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.319400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.854400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.204000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.027600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.279600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.913700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.680200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.471000E-01 |
| Normal-VS-Type2 PRCC |
7.618900E-04 |
| Normal-VS-KIRP CIMP |
6.262600E-01 |
| Normal-VS-Unclassified PRCC |
4.494800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.452450E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.990800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.112600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.132400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.303170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.993400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.39440000000735E-05 |
| Normal-vs-N1 |
2.837200E-01 |
| Normal-vs-N2 |
1.035690E-03 |
| N0-vs-N1 |
1.598010E-01 |
| N0-vs-N2 |
3.285800E-01 |
| N1-vs-N2 |
2.226200E-01 |
|
|
